Our Extended Family of Portfolio Companies

Investing in transformational ideas and entrepreneurial grit to solve major unmet needs in patient care

view more →

AtaCor Medical is developing a novel extracardiac pacing system that does not require leads or hardware to be placed inside or onto the heart.

view more →

Atsena Therapeutics is a clinical-stage, ophthalmology-focused gene therapy company

view more →

Boomerang Medical is developing a technology to advance the treatment of autoimmune diseases by using electrical nerve stimulation

view more →

Developing first-in-class approach to activate myeloid cells to kill cancer. 

view more →

Provider of a histotripsy platform designed for the treatment of cancer. Acquired by Bezos Expeditions, Wellington K5 Global 2025

view more →

Perfuse Therapeutics, Inc. is a seed stage biotechnology company focusing on improving retinal perfusion

view more →

RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke.

view more →

Tune strives to develop paradigm-changing cell and gene therapies.

view more →

Developer of health engagement platform intended to connect families to health resources on the smartphone.

“It is not the critic who counts: not the man who points out how the strong man stumbles or where the doer of deeds could have done better. The credit belongs to the man who is actually in the arena, whose face is marred by dust and sweat and blood, who strives valiantly, who errs and comes up short again and again, because there is no effort without error or shortcoming, but who knows the great enthusiasms, the great devotions, who spends himself in a worthy cause; who, at the best, knows, in the end, the triumph of high achievement, and who, at the worst, if he fails, at least he fails while daring greatly, so that his place shall never be with those cold and timid souls who knew neither victory nor defeat.”


Theodore Roosevelt
Speech at the Sorbonne, Paris, April 23, 1910